Literature DB >> 34140235

Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation.

Catherine T Haring1, Collin Brummel1, Chandan Bhambhani2, Brittany Jewell1, Molly Heft Neal1, Apurva Bhangale1, Keith Casper3, Kelly Malloy3, Scott McLean3, Andrew Shuman3, Chaz Stucken3, Andrew Rosko3, Mark Prince3, Carol Bradford3, Avraham Eisbruch4, Michelle Mierzwa4, Muneesh Tewari5, Francis P Worden5, Paul L Swiecicki5, Matthew E Spector3, J Chad Brenner6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34140235      PMCID: PMC8448944          DOI: 10.1016/j.oraloncology.2021.105332

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  13 in total

1.  Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.

Authors:  Bhishamjit S Chera; Robert J Amdur; Rebecca Green; Colette Shen; Gaorav Gupta; Xianming Tan; Mary Knowles; David Fried; Neil Hayes; Jared Weiss; Juneko Grilley-Olson; Shetal Patel; Adam Zanation; Trevor Hackman; Jose Zevallos; Jeffrey Blumberg; Samip Patel; Mohit Kasibhatla; Nathan Sheets; Mark Weissler; Wendell Yarbrough; William Mendenhall
Journal:  J Clin Oncol       Date:  2019-08-14       Impact factor: 44.544

2.  Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.

Authors:  Bhishamjit S Chera; Sunil Kumar; Brian T Beaty; David Marron; Stuart Jefferys; Rebecca Green; Emily C Goldman; Robert Amdur; Nathan Sheets; Roi Dagan; D Neil Hayes; Jared Weiss; Juneko E Grilley-Olson; Adam Zanation; Trevor Hackman; Jeffrey M Blumberg; Samip Patel; Mark Weissler; Xianming M Tan; Joel S Parker; William Mendenhall; Gaorav P Gupta
Journal:  Clin Cancer Res       Date:  2019-05-14       Impact factor: 12.531

3.  Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.

Authors:  Kristina R Dahlstrom; Guojun Li; Caroline S Hussey; Jenny T Vo; Qingyi Wei; Chong Zhao; Erich M Sturgis
Journal:  Cancer       Date:  2015-06-19       Impact factor: 6.860

4.  Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.

Authors:  Allen M Chen; Carol Felix; Pin-Chieh Wang; Sophia Hsu; Vincent Basehart; Jordan Garst; Phillip Beron; Deborah Wong; Michael H Rosove; Shyam Rao; Heather Melanson; Edward Kim; Daphne Palmer; Lihong Qi; Karen Kelly; Michael L Steinberg; Patrick A Kupelian; Megan E Daly
Journal:  Lancet Oncol       Date:  2017-04-20       Impact factor: 41.316

5.  Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer.

Authors:  G J Hanna; J G Supplee; Y Kuang; U Mahmood; C J Lau; R I Haddad; P A Jänne; C P Paweletz
Journal:  Ann Oncol       Date:  2018-09-01       Impact factor: 32.976

6.  Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.

Authors:  Mitchell Machtay; Jennifer Moughan; Andrew Trotti; Adam S Garden; Randal S Weber; Jay S Cooper; Arlene Forastiere; K Kian Ang
Journal:  J Clin Oncol       Date:  2008-06-16       Impact factor: 44.544

7.  Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.

Authors:  Sun M Ahn; Jason Y K Chan; Zhe Zhang; Hao Wang; Zubair Khan; Justin A Bishop; William Westra; Wayne M Koch; Joseph A Califano
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-09       Impact factor: 6.223

8.  Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.

Authors:  Bhishamjit S Chera; Sunil Kumar; Colette Shen; Robert Amdur; Roi Dagan; Rebecca Green; Emily Goldman; Jared Weiss; Juneko Grilley-Olson; Shetal Patel; Adam Zanation; Trevor Hackman; Jeff Blumberg; Samip Patel; Brian Thorp; Mark Weissler; Wendell Yarbrough; Nathan Sheets; William Mendenhall; Xianming M Tan; Gaorav P Gupta
Journal:  J Clin Oncol       Date:  2020-02-04       Impact factor: 44.544

9.  A mathematical model of ctDNA shedding predicts tumor detection size.

Authors:  Stefano Avanzini; David M Kurtz; Jacob J Chabon; Everett J Moding; Sharon Seiko Hori; Sanjiv Sam Gambhir; Ash A Alizadeh; Maximilian Diehn; Johannes G Reiter
Journal:  Sci Adv       Date:  2020-12-11       Impact factor: 14.136

10.  Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma.

Authors:  Catherine T Haring; Chandan Bhambhani; Collin Brummel; Brittany Jewell; Emily Bellile; Molly E Heft Neal; Erin Sandford; Ryan M Spengler; Apurva Bhangale; Matthew E Spector; Jonathan McHugh; Mark E Prince; Michelle Mierzwa; Francis P Worden; Muneesh Tewari; Paul L Swiecicki; J Chad Brenner
Journal:  Oncotarget       Date:  2021-06-22
View more
  2 in total

1.  Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma.

Authors:  Yue Cao; Catherine T Haring; Michelle Mierzwa; J Chad Brenner; Collin Brummel; Chandan Bhambhani; Madhava Aryal; Choonik Lee; Molly Heft Neal; Apurva Bhangale; Wenjin Gu; Keith Casper; Kelly Malloy; Yilun Sun; Andrew Shuman; Mark E Prince; Matthew E Spector; Steven Chinn; Jennifer Shah; Caitlin Schonewolf; Jonathan B McHugh; Ryan E Mills; Muneesh Tewari; Francis P Worden; Paul L Swiecicki
Journal:  Clin Cancer Res       Date:  2021-10-26       Impact factor: 13.801

Review 2.  De-Escalation Strategies for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma-Where Are We Now?

Authors:  Jennifer A Silver; Sena Turkdogan; Catherine F Roy; Thavakumar Subramaniam; Melissa Henry; Nader Sadeghi
Journal:  Curr Oncol       Date:  2022-05-18       Impact factor: 3.109

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.